Here are all model answers structured as per the Indian MBBS exam marking scheme (5 marks each for SAQs, 15 marks for LAQ):
SECTION "B" - Short Answer Questions (5 marks each)
a) Neonatal Sepsis [5 marks]
Definition [0.5 mark]
Neonatal sepsis is a clinical syndrome characterized by systemic signs of infection and bacteremia in the first 28 days of life. It is the most common cause of neonatal cardiorespiratory distress.
Classification [1 mark]
| Type | Onset | Features |
|---|
| Early-onset | First 7 days | Fulminant; associated with maternal/perinatal risk factors (maternal fever, GBS colonization, PROM, fetal distress); septic shock and neutropenia common |
| Late-onset | After 7 days | More gradual; less linked to risk factors; meningitis more common |
Risk factors [0.5 mark]
- Premature rupture of membranes (PROM)
- Maternal fever, GBS-positive vaginal swabs
- Low birth weight, prematurity, invasive procedures
Clinical Features [1 mark]
- Temperature instability - fever (rectal temp ≥38°C) or hypothermia (<36.5°C)
- CNS dysfunction - lethargy, irritability, seizures
- Respiratory distress - apnea, tachypnea, grunting
- Feeding disturbance - vomiting, poor feeding, abdominal distension
- Jaundice, rashes, sclerema
Causative Organisms [0.5 mark]
- Early-onset: Group B Streptococcus (GBS), E. coli, Listeria monocytogenes, Klebsiella
- Late-onset: Staphylococcus aureus, Coagulase-negative Staphylococci, gram-negative organisms
- Viral: Enteroviruses (coxsackievirus, echovirus), RSV
Investigations [0.5 mark]
- Blood culture (gold standard), CBC with differential, CRP, blood glucose
- Lumbar puncture (CSF analysis), urine culture
- Chest X-ray, serum electrolytes
Treatment [1 mark]
- Empiric antibiotics: Ampicillin + Gentamicin (first-line)
- Cefotaxime if meningitis suspected
- Duration: 10-14 days; 21 days for meningitis
- Supportive: IV fluids, oxygen, temperature regulation, glucose monitoring
b) Hemorrhagic Disease of the Newborn (HDN) [5 marks]
Definition [0.5 mark]
HDN (now called Vitamin K Deficiency Bleeding - VKDB) is a coagulation disorder of the newborn caused by a transitory deficiency of vitamin K-dependent clotting factors (II, VII, IX, X).
Etiology [0.5 mark]
- Poor placental transfer of vitamin K
- Low vitamin K content in breast milk (human milk = only ~1/5 of daily requirement)
- Maternal drugs interfering with vitamin K: phenytoin, warfarin, rifampicin, isoniazid
- Absence of gut flora in the newborn
Classification [1 mark]
| Type | Onset | Sites | Risk factor |
|---|
| Early (< 24 hours) | At birth | Cephalohematoma, intracranial, intrathoracic | Maternal drugs (warfarin, anticonvulsants) |
| Classic (1-7 days) | Day 2-5 | GI tract, umbilicus, circumcision site, skin | Breast-feeding, no prophylaxis |
| Late (2 weeks - 6 months) | 2-8 weeks | Intracranial (most dangerous), GI, skin | Exclusively breastfed, malabsorption |
Clinical Features [0.5 mark]
- Bleeding from GI tract (melena, hematemesis), umbilical stump, circumcision site
- Cephalohematoma, intracranial hemorrhage (late form - most severe)
- Pallor, prolonged bleeding from venepuncture sites
- Subarachnoid or intraparenchymal hemorrhage - neurological complications
Investigations [0.5 mark]
- Prolonged PT and aPTT, normal platelet count and bleeding time
- Low clotting factors II, VII, IX, X
- Normal fibrinogen (differentiates from DIC)
Treatment [1 mark]
- Vitamin K1 (Phytonadione):
- Mild: 1-2 mg IV/IM, repeated after 4-6 hours
- Severe/intracranial bleed: Fresh Frozen Plasma (FFP) 10-15 mL/kg immediately + Vitamin K
- Supportive: blood transfusion if required
Prevention [1 mark]
- All newborns: Vitamin K1 1 mg IM at birth (single dose - gold standard)
- Oral Vitamin K: 2 mg at birth, repeat at 1 week and 1 month (if IM refused)
- All breastfed infants should receive prophylaxis regardless
c) Neural Tube Defect (NTD) [5 marks]
Definition [0.5 mark]
NTDs are congenital malformations resulting from failure of the neural tube to close properly during the 3rd-4th week of embryonic development (18-28 days post-conception).
Etiology / Risk Factors [0.5 mark]
- Folic acid deficiency (most important preventable cause)
- Maternal diabetes, obesity, hyperthermia
- Valproate, carbamazepine (anticonvulsant use)
- Genetic factors, previous NTD-affected pregnancy
Classification [1 mark]
Cranial NTDs:
- Anencephaly: Absence of cerebral hemispheres and cranial vault; incompatible with life
- Encephalocele: Herniation of brain tissue through a skull defect
Spinal NTDs (Spina Bifida):
| Type | Features |
|---|
| Spina bifida occulta | Bony defect only; no sac; covered by skin; usually asymptomatic |
| Meningocele | Meninges herniate through defect; sac filled with CSF; no neural tissue; good prognosis |
| Myelomeningocele | Most common + severe; meninges + spinal cord/roots herniate; neurological deficits |
| Rachischisis | Complete exposure of neural tissue; most severe |
Clinical Features of Myelomeningocele [0.5 mark]
- Visible sac over lumbar/lumbosacral spine
- Lower limb weakness/paralysis, sensory loss
- Bladder and bowel dysfunction (neurogenic bladder)
- Hydrocephalus (associated with Arnold-Chiari malformation)
Investigations [0.5 mark]
- Prenatal: Elevated maternal serum AFP, amniocentesis, fetal ultrasound (18-20 weeks)
- Postnatal: MRI spine and brain, ultrasound
Management [1 mark]
- Surgical closure within 24-72 hours of birth (prevent infection)
- Hydrocephalus: VP shunt
- Physiotherapy, clean intermittent catheterization for neurogenic bladder
- Multidisciplinary care (neurosurgery, urology, orthopedics)
Prevention [1 mark]
- Folic acid 0.4 mg/day for all women of childbearing age (at least 1 month before conception and through first trimester)
- High-risk women (previous NTD child, anticonvulsant use): 5 mg/day folic acid
d) Acute Rheumatic Fever (ARF) [5 marks]
Definition [0.5 mark]
ARF is an inflammatory, non-suppurative sequela of Group A beta-hemolytic Streptococcal (GABHS) pharyngitis, involving the heart, joints, CNS, skin, and subcutaneous tissue.
Pathogenesis [0.5 mark]
Molecular mimicry: Antibodies against GABHS M-protein cross-react with cardiac tissue (sarcolemmal membrane, myosin), causing autoimmune inflammation.
Revised Jones Criteria (2015) - Diagnosis requires [1.5 marks]
Evidence of preceding streptococcal infection + 2 major OR 1 major + 2 minor criteria:
Major Criteria (JONES):
- Joints - Migratory polyarthritis (most common manifestation)
- O - Carditis (pancarditis; most serious; mitral regurgitation most common murmur)
- N - Nodules (subcutaneous, firm, painless, over bony prominences)
- E - Erythema marginatum (fleeting, non-pruritic skin rash on trunk)
- S - Sydenham's chorea (St. Vitus' dance; involuntary, purposeless movements)
Minor Criteria:
- Fever, arthralgia
- Elevated ESR / CRP
- Prolonged PR interval on ECG
Evidence of Streptococcal infection:
- Elevated/rising ASO titer (most common test used)
- Positive throat culture for GABHS
- Positive rapid streptococcal antigen test
Investigations [0.5 mark]
- ASO titer (elevated in >80% cases), throat swab culture
- ESR, CRP, CBC, ECG (prolonged PR), 2D Echo (valvular involvement)
Management [1.5 marks]
Eradication of Streptococcus:
- Benzathine Penicillin G 1.2 million units IM single dose (or Oral Penicillin V 10 days)
- Erythromycin if penicillin-allergic
Anti-inflammatory:
- Arthritis alone: Aspirin 100 mg/kg/day in divided doses x 4-6 weeks
- Carditis: Prednisolone 2 mg/kg/day x 2-3 weeks, then taper
Chorea: Haloperidol or valproate
Secondary Prophylaxis [0.5 mark]
- Benzathine Penicillin G 1.2 million units IM every 3-4 weeks
- Duration: 10 years or until age 21 (no carditis); lifetime if severe carditis with valve disease
e) Urinary Tract Infection (UTI) in Children [5 marks]
Definition [0.5 mark]
UTI is defined as significant bacteriuria (>10^5 CFU/mL in midstream urine) with clinical symptoms, indicating infection anywhere in the urinary tract.
Classification [0.5 mark]
- Upper UTI (Pyelonephritis): Fever, loin pain, renal involvement; risk of renal scarring
- Lower UTI (Cystitis): Dysuria, frequency, no fever; no renal scarring
Etiology [0.5 mark]
- Most common: E. coli (>80%)
- Others: Klebsiella, Proteus mirabilis, Enterococcus, Staphylococcus saprophyticus
- Predisposing factors: Vesicoureteral reflux (VUR), posterior urethral valves, constipation, female sex, uncircumcised males, urinary stasis
Clinical Features [0.5 mark]
- Neonates/Infants: Non-specific - fever, poor feeding, vomiting, jaundice, failure to thrive
- Older children: Dysuria, frequency, urgency, suprapubic pain, hematuria
- Pyelonephritis: High fever (>38.5°C), rigors, vomiting, loin/flank pain, CVA tenderness
Investigations [1 mark]
- Urine routine and microscopy: pyuria (>5 WBC/HPF), bacteriuria
- Urine culture and sensitivity (gold standard): clean catch midstream or suprapubic aspiration in infants
- CBC, CRP, blood culture (if toxic/< 2 months)
- Renal ultrasound (all first UTI), VCUG/MCU (for VUR), DMSA scan (cortical scarring)
Management [1.5 marks]
Antibiotics:
- Oral (uncomplicated/older children): Cotrimoxazole, nitrofurantoin, or cephalexin x 5-7 days
- Pyelonephritis/neonates/toxic children: IV Ceftriaxone or Ampicillin + Gentamicin for 10-14 days, then step down to oral
Supportive: Adequate hydration, analgesia, treat constipation
VUR management: Low-dose prophylactic antibiotics (Cotrimoxazole/Nitrofurantoin), surgical correction for high-grade VUR
Prevention [0.5 mark]
- Good perineal hygiene, adequate hydration, regular voiding, treat constipation, circumcision in boys with recurrent UTI/VUR
f) Status Asthmaticus [5 marks]
Definition [0.5 mark]
Status asthmaticus is a severe, prolonged asthma attack that does not respond to standard initial bronchodilator therapy (beta-2 agonist nebulization) and requires hospitalization and escalating treatment.
Pathophysiology [0.5 mark]
Severe bronchospasm + airway inflammation + mucus plugging -> increased airway resistance -> air trapping -> hyperinflation -> ventilation-perfusion mismatch -> hypoxemia -> hypercapnia (late sign, indicates respiratory failure)
Clinical Features / Assessment of Severity [1 mark]
| Feature | Moderate | Severe | Life-threatening |
|---|
| SpO2 | 92-95% | <92% | <90% |
| Speech | Sentences | Words/phrases | Cannot speak |
| PEFR | 50-70% | 33-50% | <33% |
| Accessory muscles | Mild | Marked | Exhaustion |
| Consciousness | Normal | Agitated | Drowsy/confused |
| PaCO2 | Normal | Rising | Hypercapnia |
Investigations [0.5 mark]
- ABG (most important - rising CO2 = impending failure), SpO2, peak flow
- CXR (exclude pneumothorax, pneumonia), CBC, electrolytes (hypokalemia from salbutamol)
- ECG in severe cases
Management - Step-wise [2 marks]
Step 1 - Immediate:
- Oxygen: High flow to maintain SpO2 >94%
- Salbutamol (albuterol): 2.5-5 mg nebulized every 20 min x 3 doses (1st hour)
- Ipratropium bromide 0.25-0.5 mg nebulized (add to salbutamol, first 2 hours)
Step 2 - Systemic Steroids (within 1 hour):
- Prednisolone 1-2 mg/kg oral (max 40 mg) OR
- Hydrocortisone 4-6 mg/kg IV if unable to take orally
Step 3 - If not improving:
- IV Magnesium Sulfate 25-75 mg/kg (max 2 g) over 20 minutes - causes bronchodilation
- IV Salbutamol infusion
- Heliox (helium-oxygen mixture) to reduce airway resistance
Step 4 - ICU / Intubation indications:
- Respiratory arrest, exhaustion, rising PaCO2, worsening consciousness, SpO2 <90% despite O2
- Mechanical ventilation: permissive hypercapnia strategy
Monitoring [0.5 mark]
- Continuous SpO2, heart rate, PEFR every 1-2 hours, ABG, electrolytes
SECTION "C" - Long Answer Question (15 marks)
Congestive Cardiac Failure (CCF) in Children [15 marks]
1. Definition [1 mark]
Congestive Cardiac Failure (CCF) / Heart Failure is a clinical syndrome in which the heart is unable to pump sufficient blood to meet the metabolic demands of the body, or can do so only at elevated filling pressures, resulting in systemic and pulmonary venous congestion.
2. Classification [2 marks]
A. By onset:
- Acute CCF: Sudden onset (myocarditis, arrhythmia, acute rheumatic fever)
- Chronic CCF: Gradual onset (congenital heart disease - most common cause in children)
B. By side of failure:
- Left heart failure: Pulmonary venous congestion - dyspnea, orthopnea, pulmonary edema
- Right heart failure: Systemic venous congestion - hepatomegaly, edema, JVD
- Biventricular (Congestive): Both sides (most common in children)
C. By functional classification (Ross Classification for children / Modified NYHA):
| Class | Symptoms |
|---|
| I | Asymptomatic |
| II | Mild symptoms with ordinary activity |
| III | Marked limitation; comfortable only at rest |
| IV | Symptoms at rest |
3. Causes [3 marks]
A. Congenital Heart Disease (most common in infants/children):
- Left-to-right shunts (volume overload): VSD (most common congenital heart defect), ASD, PDA, AVSD
- Obstructive lesions (pressure overload): Aortic stenosis, Pulmonary stenosis, Coarctation of aorta
- Complex/cyanotic CHD: Tetralogy of Fallot (after repair), Transposition of great arteries
B. Acquired Heart Disease:
- Myocarditis (viral - Coxsackie B, adenovirus; most common acquired cause)
- Dilated Cardiomyopathy
- Acute Rheumatic Fever (carditis)
- Infective Endocarditis
- Kawasaki disease (coronary artery aneurysm/MI)
C. Non-cardiac causes:
- Severe anemia (high-output failure) - most common non-cardiac cause in India
- Hypertension (hypertensive crisis)
- Arrhythmias (SVT, complete heart block)
- Thyrotoxicosis, sepsis
4. Pathophysiology [2 marks]
Decreased cardiac output → Activation of compensatory mechanisms:
- Sympathetic activation: Tachycardia, vasoconstriction (increases afterload, increases myocardial O2 demand)
- RAAS activation: Renin → Angiotensin II → Aldosterone → Na and water retention → increased preload → edema and congestion
- Frank-Starling mechanism: Increased preload → increased stroke volume (limited; eventually fails)
- Ventricular hypertrophy/remodeling: Initially compensatory, eventually leads to worsening dysfunction
These compensatory mechanisms eventually become maladaptive, perpetuating the cycle of heart failure.
5. Clinical Features [3 marks]
Infants (<2 years) - Most common presentation:
- Poor feeding, failure to thrive (most common symptom in infants)
- Tachycardia (>160/min), tachypnea (>60/min), grunting
- Sweating during feeding (due to increased sympathetic activity)
- Hepatomegaly (cardinal sign - most sensitive sign in children)
- Pulmonary congestion: Wheeze, crepitations, respiratory distress
- Periorbital edema (dependent edema in infants)
Older children:
- Dyspnea on exertion, orthopnea, paroxysmal nocturnal dyspnea
- Exercise intolerance, fatigue, poor weight gain
- Peripheral pitting edema (pedal edema), ascites
- Raised JVP, gallop rhythm (S3), cardiomegaly
Signs on examination:
- Cardiomegaly (displaced apex beat)
- Gallop rhythm (S3 - most important auscultatory sign)
- Tender hepatomegaly (right heart failure)
- Basal crackles (left heart failure)
6. Investigations [2 marks]
| Investigation | Findings in CCF |
|---|
| Chest X-ray | Cardiomegaly (CTR >0.55), pulmonary plethora, Kerley B lines, pleural effusion |
| ECG | Tachycardia, LVH or RVH, arrhythmias, ST-T changes |
| 2D Echocardiography | Most important - identifies structural defect, ejection fraction (EF<55% = systolic dysfunction), wall motion abnormalities |
| BNP/NT-proBNP | Elevated (most specific biomarker for heart failure) |
| Blood tests | CBC (anemia), electrolytes, BUN, creatinine, LFT, thyroid function |
| Cardiac catheterization | For complex CHD requiring surgical planning |
7. Management [2 marks]
General Measures:
- Rest, head-end elevation (30-45 degrees), oxygen supplementation
- Fluid restriction, salt restriction in older children
- Treat precipitating cause (infection, anemia, arrhythmia)
Pharmacological Treatment:
Diuretics (first-line for symptomatic relief):
- Furosemide (Loop diuretic): 1-2 mg/kg/dose IV or oral - reduces preload
- Spironolactone (Aldosterone antagonist): 2-3 mg/kg/day - potassium-sparing, reduces remodeling
Digoxin (Positive inotrope + rate control):
- Digitalizing dose: 30-40 mcg/kg oral over 24 hours
- Maintenance: 10 mcg/kg/day in 2 divided doses
- Monitor for toxicity: bradycardia, arrhythmia, nausea, vomiting
ACE Inhibitors (afterload reduction - standard of care):
- Captopril: 0.5-1 mg/kg/day in 3 divided doses
- Enalapril: 0.1 mg/kg/day; reduces mortality and hospitalizations
Beta-blockers (chronic heart failure with reduced EF):
- Carvedilol: 0.1 mg/kg/dose, titrate up slowly
Inotropic support (acute severe CCF):
- Dobutamine infusion (2-20 mcg/kg/min) or Dopamine (5-20 mcg/kg/min) in ICU
Surgical/Interventional Treatment:
- Surgical correction of underlying CHD (VSD closure, valve repair, Fontan procedure)
- Cardiac resynchronization therapy (CRT) for dyssynchrony
- Cardiac transplantation: End-stage refractory CCF
Reference: Nelson Textbook of Pediatrics (21st Ed.) | OP Ghai's Textbook of Pediatrics (9th Ed.) | IAP Textbook of Pediatrics